Company intelligence / Profile preview

Analytics4Life

Toronto, Ontario, Canadaanalytics4life.com ↗

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

The CorVista System enables non-invasive point-of-care assessment for coronary artery disease and other cardiovascular conditions using machine learning models trained on high-fidelity cardiac signals. Clinical studies have included over 10,000 patients with more than 2,000 enrolled in pivotal U.S. trials; results are processed rapidly at the point of care without radiation or contrast agents. The system’s performance data were to be presented at major cardiology conferences.

Therapeutic areas: Cardiovascular
Modalities: DeviceArtificial intelligence-based diagnostic platform
Industry: Physiological Monitoring

Partnerships

CorVista Health (exclusive commercial partner for U.S.)

Beyond the preview

Go deeper on Analytics4Life.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Analytics4Life.

Explore the full profile